(Q45400772)
Statements
A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein-Barr virus DNA as a biomarker of efficacy (English)
Edwin P Hui
K F To
Frankie Mo
Sing F Leung
Michael Kam
1 reference